13 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
A new class of pseudopeptide antagonists of the kinin B1 receptor containing alkyl spacers.
Institute of Mutagenesis and Differentiation
Quinolinyl- and phenantridinyl-acetamides as bradykinin B1 receptor antagonists.
Gedeon Richter
Alpha-hydroxy amides as a novel class of bradykinin B1 selective antagonists.
Merck Research Laboratories
Benzodiazepines as potent and selective bradykinin B1 antagonists.
Merck Research Laboratories
Bradykinin B1 receptor antagonists as potential therapeutic agents for pain.
Johnson & Johnson Pharmaceutical Research and Development
Synthesis and biological activity of new bradykinin pseudopeptide B1 receptor agonists containing alkylic spacers
TBA
1-Benzylbenzimidazoles: the discovery of a novel series of bradykinin B(1) receptor antagonists.
Neurogen
Potent nonpeptide antagonists of the bradykinin B1 receptor: structure-activity relationship studies with novel diaminochroman carboxamides.
Amgen
Identification of a nonpeptidic and conformationally restricted bradykinin B1 receptor antagonist with anti-inflammatory activity.
Amgen
Development of orally bioavailable and CNS penetrant biphenylaminocyclopropane carboxamide bradykinin B1 receptor antagonists.
Merck Research Laboratories
Development of an efficient and selective radioligand for bradykinin B1 receptor occupancy studies.
Merck Research Laboratories